Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2007
12/26/2007CN100357737C Specific combination reaction analyzing method, analyzer and used kit
12/26/2007CN100357736C Fast detection device for salmonella
12/26/2007CN100357735C High temperature high pressure oil well cement paste coagulation instrument and its coagulation time measuring method
12/26/2007CN100357734C Quality control method for children hyperkinetic symptom therapeutic traditional Chinese medicine formulation
12/26/2007CN100357729C Electrode for active oxygen species and sensor using the electrode
12/26/2007CN100357727C Electrochemcial immunoassay for tumor marker and small size immunoassay chip
12/26/2007CN100357433C eNOS mutations useful for gene therapy and therapeutic screening
12/26/2007CN100357426C Culture and collection of dermatophagoides pteronyssinus and method for preparing its allergen diagnosis and treatment preparation
12/26/2007CN100357391C Fine particle containing rare earth element and fluorescent probe using the same
12/26/2007CN100357324C Effectors of innate immunity
12/26/2007CN100357320C ZIBC gene and its coded protein and uses
12/26/2007CN100356929C Medicinal composition for auxiliary treatment of asthenia healthy qi and its quality control method
12/26/2007CN100356901C Pseudo body odor composition and perfume composition for inhibiting body odor
12/26/2007CA2610439A1 Unit dosage forms of temozolomide
12/25/2007US7313482 Selection of target sites for antisense attack of RNA
12/25/2007US7312453 Methods for determining corrosion products on substrates using infrared imaging
12/25/2007US7312451 Determination of dough development using near infrared radiation
12/25/2007US7312373 Nonhuman model animal lacking the ability to control lymphocyte migration
12/25/2007US7312326 Fluorescent labeled nucleotide derivatives
12/25/2007US7312322 Genetic sequences encoding steroid and juvenile hormone receptor polypeptides and insecticidal modalities therefor
12/25/2007US7312321 Antibody to human enzymes of the metalloprotease family
12/25/2007US7312317 P2Y4 antibodies
12/25/2007US7312316 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides
12/25/2007US7312315 PRO9742 antibodies
12/25/2007US7312314 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
12/25/2007US7312313 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
12/25/2007US7312312 PRO6242 polypeptides
12/25/2007US7312311 Attaching substances to microorganisms
12/25/2007US7312309 For release of tumor necrosis and or cellular differentation/proliferation of chrondrocytes by contacting blood w/polypeptides; cancer diagnosis
12/25/2007US7312308 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
12/25/2007US7312302 Compositions for the detection of enzyme activity in biological samples and methods of use thereof
12/25/2007US7312095 Modification of selectivity for sensing for nanostructure sensing device arrays
12/25/2007US7312090 Spectrophotometric evaluation of bodily fluid; genome analysis and diagnostics; detecting binding or cleavage of one or more specific binding substances to the colorimetric resonant reflectance optical biosensor surface, or to their respective binding partners which are immobilized
12/25/2007US7312089 Contacting biological sample with antibodies having specific binding affinity for erytrhopoetin receptor(EpoR), detecting presence, absence, or amount of EpoR by identifying the human blood progenitor cells having antibody bound thereto
12/25/2007US7312087 Devices and methods for biochip multiplexing
12/25/2007US7312086 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders
12/25/2007US7312085 Apparatus for manipulation and/or detection of cells and/or beads
12/25/2007US7312083 Control value assignment method
12/25/2007US7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/25/2007US7312074 construct comprising a complex of a recombinant single-stranded polynucleotide and a chimeric protein produced in a host cell transformed with said recombinant polynucleotide and extruded therefrom without lysis of the host cell
12/25/2007US7312073 fast detection and enumeration of low concentration of viable microorganisms using organic or inorganic substances that are entrapped in porous sol-gel glass
12/25/2007US7312071 Effective monitoring system for anthrax smallpox, or other pathogens
12/25/2007US7312070 β-catenin oligonucleotide microchip and method for detecting β-catenin mutations employing same
12/25/2007US7312069 Method of analyzing ligand in sample and apparatus for analyzing ligand in sample
12/25/2007US7312068 Forming high density arrays with smaller feature size and spacings; efficient reagent usage
12/25/2007US7312060 Non-radioactive markers that facilitate the detection and analysis of nascent proteins translated within cellular or cell-free systems; preferred markers are dipyrrometheneboron difluoride
12/25/2007US7312057 Method for reducing binding of organic material to hydrophobic surfaces
12/25/2007US7312046 Method of screening compounds using a nanoporous silicon support containing macrowells for cells
12/25/2007US7312044 Type 1 ryanodine receptor-based methods
12/25/2007US7312043 Classifying activity of membrane protein modulators; obtain cells, expose to modulators, pulse cells with electricity, detecting fluorescence emission from cells
12/25/2007US7312042 Embossed cell analyte sensor and methods of manufacture
12/25/2007US7312041 Methods of diagnosing cervical cancer
12/25/2007US7312040 Microcapsule biosensors and methods of using the same
12/25/2007US7312038 Photocleavable bioreactive agents
12/25/2007US7312032 Transgenic mammalian cells for use diagnostic tool in monitoring cell activities
12/25/2007US7312031 Alpha-complementation viral fusion assay
12/25/2007US7312028 Antibody-immobilized microporous membrane; breadth corner layer directly attached to a semi-rigid liquid-impervious body with water insoluble adhesive; separate absorbent body is wetted and placed next to the lower membrane surface to forming networks of capillary channels
12/25/2007US7312027 Binding assay device with non-absorbent carrier material
12/25/2007US7312024 Anticancer agents; administering interleukin polypeptide
12/25/2007US7311921 Effective against FIVDix, FIVUK8, FIVBang, FIVAom1, FIVAom2, FIVPet, and FIVShi.
12/25/2007US7311920 Virus coat protein/receptor chimeras and methods of use
12/25/2007US7311917 Membrane proteins; fusion proteins; vaccines; kits
12/25/2007US7311915 peptide mixture; induce immunology response; gag protein; vaccines
12/25/2007US7311914 Contacting a biological sample isolated from a patient with an agent that is specific for a MAGE-A4 HLA-B37 binding peptide, and determining the interaction between the agent and the MAGE-A4 HLA-B37 binding peptide as a determination of cancer
12/25/2007US7311909 PRO4348 antibodies
12/25/2007US7311906 Administering anti-TK1 antibody conjugated to cytotoxic agent consisting of pokeweed antiviral protein (PAP), ricin, abrin, gelonin, saporin, and alpha-sarcin; detecting and diagnosing viral infections
12/25/2007US7311848 Monitoring fluid liquid mixture or one component therein by pressurising and supplying mixture to separation apparatus comprising rotatable discs and means for withdrawing a dense fraction of liquid mixture from perimeter of disks; separation of pulp and paper suspensions; papermaking; efficiency
12/25/2007US7311826 Integrated high throughput system for the analysis of biomolecules
12/25/2007US7311812 Biosensor
12/25/2007US7311011 Apparatuses for interaction with a subterranean formation, and methods of use thereof
12/25/2007US7310991 Explosion-proof gas sensor
12/21/2007WO2007147165A2 Human cancer stem cell culture compositions comprising erbb2 variants and methods of use thereof
12/21/2007WO2007147141A2 Methods for detecting molecular complexes
12/21/2007WO2007147002A2 Beta-peptide lyotropic liquid crystals and methods of manufacture and use thereof
12/21/2007WO2007146996A2 Labels for electronic detection of individual molecules and methods for their detection
12/21/2007WO2007146702A2 Method for detecting il-16 activity and modulation of il-16 activity based on rantes proxy levels
12/21/2007WO2007146385A2 Albumin-bound protein/peptide complex as a biomarker for disease
12/21/2007WO2007146378A2 Diagnostic apparatus
12/21/2007WO2007146334A2 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007WO2007146268A2 Methods for reducing or preventing liquid-liquid phase separation in high concentration protein salutions
12/21/2007WO2007146267A2 Disease model incorporation into an artificial immune system (ais)
12/21/2007WO2007146229A2 Markers associated with arteriovascular events and methods of use thereof
12/21/2007WO2007146171A2 Purified high molecular weight adiponectin and uses thereof
12/21/2007WO2007146158A1 Dna sequencing by nanopore using modified nucleotides
12/21/2007WO2007146156A2 Biological fixative and method of using the biological fixative
12/21/2007WO2007146061A2 Cell collection and disease screening
12/21/2007WO2007146047A1 Patches, systems, and methods for non-invasive glucose measurement
12/21/2007WO2007146023A1 Cholesterol-regulating complex of sirt1 and lxr and methods of use
12/21/2007WO2007145697A2 Directed-flow assay device
12/21/2007WO2007145658A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007WO2007145529A1 Fluid analysing system technology
12/21/2007WO2007145365A1 Therapeutic agent for cancer and method for screening for the same
12/21/2007WO2007145362A1 Glyceroglycolipid antigen of mycoplasma pneumoniae
12/21/2007WO2007145333A1 Immunity evaluation method, immunity evaluation apparatus, immunity evaluation program and data recording medium having the immunity evaluation program stored therein
12/21/2007WO2007145326A1 Method for determination of inflammatory disease
12/21/2007WO2007145298A1 Method of, and apparatus for, detecting of any interaction between nucleic acid and protein
12/21/2007WO2007145274A1 METHOD FOR EXAMINATION OF LUNG INJURY BY MEASURING CYTOCHROME-c, AND TEST KIT
12/21/2007WO2007145213A1 Control of the formation of double-stranded dna
12/21/2007WO2007145192A1 Collagen type iv-like immunoreactive peptide
12/21/2007WO2007144974A1 Autoimmune nonhuman animal and screening method using the same